Alpha Teknova (TKNO) Liabilities and Shareholders Equity (2020 - 2026)

Alpha Teknova's (TKNO) quarterly Liabilities and Shareholders Equity came in at $98.7 million in Q1 2026, down 13.45% year-on-year from $114.0 million in Q1 2025, and down 4.76% on a QoQ basis from $103.6 million in Q4 2025.

Alpha Teknova (TKNO) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends

Alpha Teknova (TKNO) has 7 years of Liabilities and Shareholders Equity data on file, last reported at $98.7 million in Q1 2026.

  • On a quarterly basis, Liabilities and Shareholders Equity fell 13.45% year-over-year to $98.7 million in Q1 2026; TTM through Mar 2026 was $420.4 million, a 10.98% decrease from a year earlier, with the FY2025 full-year figure at $103.6 million, down 12.79% from the prior year.
  • Liabilities and Shareholders Equity for Q1 2026 stood at $98.7 million, down from $103.6 million in the prior quarter.
  • Over the last five years, Liabilities and Shareholders Equity for TKNO reached as high as $184.1 million in Q1 2022 and fell as low as $98.7 million in Q1 2026.
  • Historically, Liabilities and Shareholders Equity has averaged $131.3 million across 5 years, with a median of $124.1 million in 2024.
  • Across the five-year window, Liabilities and Shareholders Equity increased 5.58% in 2022 and dropped 27.25% in 2023, its largest moves.
  • Year by year, Liabilities and Shareholders Equity stood at $152.3 million in 2022, then slipped by 15.55% to $128.6 million in 2023, then retreated by 7.64% to $118.8 million in 2024, then fell by 12.79% to $103.6 million in 2025, then slipped by 4.76% to $98.7 million in 2026.
  • Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $98.7 million in Q1 2026, $103.6 million in Q4 2025, and $107.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 43.40 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 40.04 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 15.15 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 98.91 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 6.71 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 69.30 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 36.83 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 4.91 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 13.22 Bn
10 Alpha Teknova 278.75 Mn 260.97 Mn 3.78 Mn 98.66 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 98.66 Mn
Dec 31, 2025 103.58 Mn
Sep 30, 2025 107.63 Mn
Jun 30, 2025 110.49 Mn
Mar 31, 2025 113.99 Mn
Dec 31, 2024 118.77 Mn
Sep 30, 2024 124.10 Mn
Jun 30, 2024 115.35 Mn
Mar 31, 2024 120.82 Mn
Dec 31, 2023 128.59 Mn
Sep 30, 2023 138.39 Mn
Jun 30, 2023 132.55 Mn
Mar 31, 2023 141.02 Mn
Dec 31, 2022 152.26 Mn
Sep 30, 2022 160.27 Mn
Jun 30, 2022 182.20 Mn
Mar 31, 2022 184.08 Mn
Dec 31, 2021 166.51 Mn
Sep 30, 2021 169.16 Mn
Jun 30, 2021 172.57 Mn